Mechanisms and physiological implications of cooperative gating of clustered ion channels

RE Dixon, MF Navedo, MD Binder… - Physiological …, 2022 - journals.physiology.org
Ion channels play a central role in the regulation of nearly every cellular process. Dating
back to the classic 1952 Hodgkin–Huxley model of the generation of the action potential, ion …

[HTML][HTML] Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models

M Trombetta-Lima, AM Sabogal-Guáqueta, AM Dolga - Cell Calcium, 2021 - Elsevier
Progressive neuronal loss is a hallmark of many neurodegenerative diseases, including
Alzheimer's and Parkinson's disease. These pathologies exhibit clear signs of inflammation …

Calcium homeostasis in Parkinson's disease: from pathology to treatment

J Zhang, Q Shen, Y Ma, L Liu, W Jia, L Chen… - Neuroscience Bulletin, 2022 - Springer
Abnormal aggregation of α-synuclein is thought to be one of core pathogenic factors in PD.
Ca2+ can bind to the C-terminus of α-synuclein, regulate the secretion of α-synuclein, and …

Isradipine plasma pharmacokinetics and exposure–response in early Parkinson's disease

CS Venuto, L Yang, M Javidnia… - Annals of clinical …, 2021 - Wiley Online Library
Objectives Isradipine is a dihydropyridine calcium channel inhibitor that has demonstrated
concentration‐dependent neuroprotective effects in animal models of Parkinson's disease …

[HTML][HTML] Voltage-Gated Ca2+ Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?

NJ Ortner - Frontiers in synaptic neuroscience, 2021 - frontiersin.org
The loss of dopamine (DA)-producing neurons in the substantia nigra pars compacta (SN)
underlies the core motor symptoms of the progressive movement disorder Parkinson's …

[HTML][HTML] Ferritinophagy and α-Synuclein: pharmacological targeting of autophagy to restore iron regulation in Parkinson's disease

MK Boag, A Roberts, VN Uversky, L Ma… - International journal of …, 2022 - mdpi.com
A major hallmark of Parkinson's disease (PD) is the fatal destruction of dopaminergic
neurons within the substantia nigra pars compacta. This event is preceded by the formation …

Tonic activation of NR2D-containing NMDARs exacerbates dopaminergic neuronal loss in MPTP-injected Parkinsonian mice

R Sharma, C Neupane, TL Pham, M Lee… - Journal of …, 2023 - Soc Neuroscience
NR2D subunit-containing NMDA receptors (NMDARs) gradually disappear during brain
maturation but can be recruited by pathophysiological stimuli in the adult brain. Here, we …

[HTML][HTML] GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

L Cheslow, M Byrne, JS Kopenhaver, L Iacovitti… - npj Parkinson's …, 2024 - nature.com
Mitochondrial dysfunction and reactive oxygen species (ROS) accumulation within the
substantia nigra pars compacta (SNpc) are central drivers of dopaminergic (DA) neuron …

[HTML][HTML] The role of voltage-gated calcium channels in basal ganglia neurodegenerative disorders

BHM Correa, CR Moreira, ME Hildebrand… - Current …, 2023 - ncbi.nlm.nih.gov
Abstract Calcium (Ca 2+) plays a central role in regulating many cellular processes and
influences cell survival. Several mechanisms can disrupt Ca 2+ homeostasis to trigger cell …

[HTML][HTML] Biomarkers for Managing Neurodegenerative Diseases

L Cheslow, AE Snook, SA Waldman - Biomolecules, 2024 - mdpi.com
Neurological disorders are the leading cause of cognitive and physical disability worldwide,
affecting 15% of the global population. Due to the demographics of aging, the prevalence of …